AAS
AHCO icon

Ameritas Advisory Services’s AdaptHealth AHCO Stock Holding History

Ameritas Advisory Services’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-750
Closed -$9.32K – 595
2023
Q1 		$9.32K Buy
+750
New +$13.8K ﹤0.01% 1917

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Advisory Services's AHCO Position: Q2 2023 in Review

Ameritas Advisory Services sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 750 shares — an estimated $9.32K sold.

Ameritas Advisory Services first reported a position in AHCO in Q1 2023 and held it in 1 quarter. The position peaked at $9.32K in Q1 2023. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • Ameritas Advisory Services reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 750 AdaptHealth shares in Q2 2023, an estimated $9.32K.
  • Ameritas Advisory Services first reported a position in AdaptHealth in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's AdaptHealth position peaked at $9.32K in Q1 2023.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.